Login to Your Account



Bench Press: BioWorld Looks at Translational Medicine


Monday, June 24, 2013
Several successful cancer drugs target receptor tyrosine kinases, which phosphorylate proteins to activate them. Now, a group from the Singaporean Agency for Science, Technology and Research has shown that a protein phosphatase may be a useful target for preventing metastasis in triple-negative breast cancer.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription